[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n N+bGAO+Q4VZKJVD6oy0qLPPWQADog2TogCBGGPdwrQIvADJpGLOgOGW2+lZ+DFL8\n 3/V7+UsEVVm90hNlY+ns1g==\n\n', u'0000874733-04-000102.txt : 20040831\n', u'0000874733-04-000102.hdr.sgml : 20040831\n', u'20040831163901\nACCESSION NUMBER:\t\t0000874733-04-000102\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t1\nCONFORMED PERIOD OF REPORT:\t20040630\nITEM INFORMATION:\t\tEntry into a Material Definitive Agreement\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nFILED AS OF DATE:\t\t20040831\nDATE AS OF CHANGE:\t\t20040831\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tMEDIWARE INFORMATION SYSTEMS INC\n\t\tCENTRAL INDEX KEY:\t\t\t0000874733\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tSERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]\n\t\tIRS NUMBER:\t\t\t\t112209324\n\t\tSTATE OF INCORPORATION:\t\t\tNY\n\t\tFISCAL YEAR END:\t\t\t0630\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-10768\n\t\tFILM NUMBER:\t\t041008848\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t11711 WEST 79TH STREET\n\t\tCITY:\t\t\tLENEXA\n\t\tSTATE:\t\t\tKS\n\t\tZIP:\t\t\t66214\n\t\tBUSINESS PHONE:\t\t9133071000\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\t11711 WEST 79TH STREET\n\t\tCITY:\t\t\tLENEXA\n\t\tSTATE:\t\t\tKS\n\t\tZIP:\t\t\t66214\n', u'\n', u'\n', u'8-K\n', u'1\n', u'form8kaugust04.htm\n', u'\n', u'\n', u'FORM 8-K', u'\n', u'\n', u'\xa0', u'\n', u'SECURITIES AND EXCHANGE COMMISSION', u'\n', u'Washington, D.C.  20549', u'\n', u'\n', u'FORM 8-K', u'\n', u'\n', u'CURRENT REPORT', u'\n', u'Pursuant to Section 13 or 15(d) of the', u'\nSecurities Exchange Act of 1934', u'\n', u'\n', u'Date of Report (Date of earliest event reported): August 25, 2004', u'\n', u'\xa0', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Mediware Information Systems, Inc.\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u'(Exact name of registrant as specified in its charter)', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0New York\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa01-10768\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa011-2209324\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u'\n', u'\n', u'(State or other jurisdiction', u'\nof incorporation)', u'\n', u'\n', u'(Commission File Number)', u'\n', u'\n', u'(IRS Employer', u'\nIdentification No.)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa011711 West 79th Street, Lenexa, KS\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa066214\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u'\n', u'\n', u'(Address of principal executive offices)', u'\n', u'\n', u'(Zip Code)', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u"Registrant's telephone number, including area code", u'\xa0\xa0\xa0\xa0\xa0(913) 307-1000\xa0\xa0\xa0\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0', u'\n(Former name or former address, if changed since last report)', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:', u'\n', u'[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)', u'\n', u'[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)', u'\n', u'[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))', u'\n', u'[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Item 1.01\xa0\xa0\xa0\xa0\xa0\xa0Entry into a Material Definitive Agreement.', u'\n', u'\n', u' ', u'\n', u'\t\tOn August 25, 2004, Mediware Information Systems, Inc. (the "Company") entered into an employment agreement (the "Agreement") with George J. Barry, the Company\'s Chief Executive Officer and President (the "CEO").', u'\n', u'\n', u'\t\tPursuant to the Agreement, the Company will continue to employ Mr. Barry as Chief Executive Officer and President.  The term of employment under the Agreement is 2 years.  The Agreement will automatically renew for successive 1 year terms unless either the Company or the CEO gives timely notice of non-renewal.', u'\n', u'\n', u'\t\tThe Agreement provides for an annual base salary of $300,000 and a discretionary bonus of up to $150,000 per year during the term of the Agreement.  The Agreement grants the CEO 25,000 restricted shares (the "Restricted Shares") of the Company\'s common stock, par value $.10 per share ("Common Stock"), pursuant to the Company\'s 2003 Equity Incentive Plan (the "Plan").  The Restricted Shares vest on August 25, 2005 only if the CEO is employed by the Company on such date.  Upon an acquisition or sale of the Company, as defined in the Agreement, any unvested Restricted Shares immediately vest. ', u'\n', u'\n', u'\t\tIn addition, if the Company\'s shareholders approve an amendment to the Plan that increases the number of shares of Common Stock subject to the Plan on or before August 25, 2005 (the "Amendment"), the CEO will immediately be granted 25,000 additional restricted shares under the Plan, provided that the CEO is employed by the Company on such date. The additional restricted shares will vest on August 24, 2006, if the CEO is employed by the Company on such date.  Upon an acquisition or sale of the Company (as defined in the Agreement), these shares will immediately vest.  If there is an acquisition or sale of the Company before the Amendment is approved and the CEO is employed by the Company, the CEO will receive an equivalent cash payment in lieu of a grant of additional restricted shares.  If the Amendment is not approved on or before August 25, 2005, the Agreement will terminate on August 25, 2005, any unvested restricted shares will be forfeited and the CEO will not be eli\ngible for the cash bonus.', u'\n', u'\n', u'\t\tIn addition to termination for disability, death, cause or failure of the Amendment to be approved on or before August 25, 2005, the Agreement may be terminated  (i) by either the Company or the CEO without cause upon 90 days prior written notice and (ii) by the CEO for Good Reason (as defined in the Agreement).  ', u'\n', u'\n', u"\t\tIf the Company terminates the CEO's employment without cause or the CEO terminates the Agreement for Good Reason, the Company will pay the CEO an amount equal to 12 months of the CEO's annual salary at the highest rate in effect during the term of employment and will provide the CEO with certain health insurance coverage.  If the CEO voluntarily resigns his employment, the Company will pay the CEO an amount equal to 3 months annual salary at the highest rate in effect during the term of employment and will provide the CEO with certain health insurance coverage.  If a third party terminates the CEO due to an acquisition or sale of the Company, the Company will pay the CEO an amount equal to 12 months of the CEO's annual salary at the rate in effect at the date of termination and will provide the CEO with certain health insurance coverage.  ", u'\n', u"The Agreement provides for a 1 year non-compete covenant by the CEO following the date of termination of the CEO's employment with the Company.", u'\n', u'\n', u'\n', u'Item 2.02\xa0\xa0\xa0\xa0\xa0\xa0Results of Operations and Financial Condition.', u'\n', u'\n', u'\n', u'On August 31, 2004, the Company issued a press release announcing its financial results for the year ended June 30, 2004.  The press release is attached hereto as Exhibit 99.1.', u'\n', u'\n', u'\n', u'Item 9.01\xa0\xa0\xa0\xa0\xa0\xa0Financial Statements and Exhibits.', u'\n', u'(c)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Exhibits.', u'\n', u'Exhibit 99.1\xa0\xa0\xa0Press Release of Mediware Information Systems, Inc., dated August 31, 2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'SIGNATURES', u'\n', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'MEDIWARE INFORMATION SYSTEMS, INC', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Date:\tAugust 31, 2004', u'\n', u'\n', u'By:\xa0\xa0', u'/s/ George J. Barry', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0George J. Barry', u'\n\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Chief Executive Officer and President', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'EXHIBIT INDEX', u'\n', u'\n', u'\n', u'\n', u'Exhibit No.', u'\n', u'\n', u'\n', u'Description', u'\n', u'\n', u'\n', u'\n', u'99.1', u'\n', u'\n', u'Press Release of Mediware Information Systems, Inc., dated August 31, 2004', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'EXHIBIT 99.1', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Contact', u'\n', u'\n', u'George Barry', u'\n913/307-1000', u'\nwww.mediware.com', u'\n', u'\n', u'Thomas Redington', u'\n203/222-7399', u'\n212/926-1733', u'\nwww.redingtoninc.com', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Mediware Reports Fiscal 2004 Results', u'\n', u'\n', u'Fourth Quarter Caps Third Consecutive Year of Record ', u'\nRevenue: Full Year Income Dampened by Expected Costs of New', u'\nProduct Launches ', u'\n', u'\n', u'\xa0', u'\n', u'LENEXA, KS AUG. 31 -- Mediware Information Systems, Inc. (Nasdaq: MEDW) reported its third consecutive year of record revenue for the fiscal year ended June 30, 2004 of $36.7 million, up 11 percent compared to $33.0 million for fiscal 2003. Operating income for the year just ended was $5.6 million versus $7.0 million for the prior year.', u'\n', u'Net income for fiscal 2004 was $3.6 million, or 48 cents per basic share and 44 cents per fully diluted share, compared to net income of $4.4 million, or 60 cents per basic share and 56 cents per fully diluted share.', u'\n', u'For the quarter just ended, revenue was $9.2 million, up 5 percent from the year-ago period.  Net income for the fourth quarter of fiscal 2004 decreased to $875,000, or 12 cents per basic share and 11 cents per diluted share, compared to $1,169,000, or 16 cents per basic share and 15 cents per fully diluted share, for the fourth quarter of fiscal 2003.', u'\n', u'Commenting on the quarter and the year, George Barry, Mediware\'s CEO, said, "Fiscal 2004 included the introduction of our new blood bank transfusion system along with the early release of our computerized clinician order entry and medication administration solutions from our pharmacy division.  Annual results were dampened by approximately $1.5 million of new product amortization costs along with other related marketing rollout and infrastructure buildup costs.   We are pleased with the early acceptance and field performance of these new products and anticipate they will substantially add to our future growth rates, beginning in the current fiscal year."', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Fourth Quarter and Annual Fiscal', u'\n2004 and 2003 Operating Statement Highlights', u'\n(in thousands) (unaudited):', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'Three Months Ended', u'\nJune 30', u'\n', u'\n', u'Twelve Months Ended', u'\nJune 30', u'\n', u'\n', u'\xa0', u'\n', u'\n', u' ', u'2004', u'\n', u'\n', u' ', u'2003', u'\n', u'\n', u'2004', u'\n', u'\n', u'2003', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0System Sales', u'\n', u'\n', u'$ 3,247 ', u'\n', u'\n', u'$ 3,071 ', u'\n', u'\n', u'$ 12,421', u'\n', u'\n', u'$ 12,564', u'\n', u'\n', u'\n', u'\xa0\xa0Services', u'\n', u'\n', u'$ 5,967 ', u'\n', u'\n', u'$ 5,734 ', u'\n', u'\n', u'$ 24,233', u'\n', u'\n', u'$ 20,419', u'\n', u'\n', u'\n', u'Total Revenue', u'\n', u'\n', u'$ 9,214', u'\n', u'\n', u'$ 8,805', u'\n', u'\n', u'$ 36,654', u'\n', u'\n', u'$ 32,983', u'\n', u'\n', u'\n', u'   Operating Expenses', u'\n', u'\n', u'$ 7,796', u'\n', u'\n', u'$ 7,051', u'\n', u'\n', u'$ 31,011', u'\n', u'\n', u'$ 26,645', u'\n', u'\n', u'\n', u'   Proceeds from Settlement', u'\n', u'\n', u'$ \xa0\xa0\xa0\xa0\xa0\xa0\xa00', u'\n', u'\n', u'$ \xa0\xa0\xa0\xa0\xa0\xa0\xa00', u'\n', u'\n', u'$ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa00      ', u'\n', u'\n', u'($ \xa0\xa0\xa0614)', u'\n', u'\n', u'\n', u'Operating Income ', u'\n', u'\n', u'$ 1,418 ', u'\n', u'\n', u'$ 1,754 ', u'\n', u'\n', u'$ \xa05,643', u'\n', u'\n', u'$ \xa06,952', u'\n', u'\n', u'\n', u'Net Earnings ', u'\n', u'\n', u'$ \xa0\xa0\xa0875', u'\n', u'\n', u'$ 1,169', u'\n', u'\n', u'$ \xa03,607', u'\n', u'\n', u'$ \xa04,389', u'\n', u'\n', u'\n', u'Earnings Per Basic Share', u'\n', u'\n', u'$ \xa0\xa00.12', u'\n', u'\n', u'$ \xa0\xa00.16', u'\n', u'\n', u'$ \xa0\xa0\xa00.48', u'\n', u'\n', u'$ \xa0\xa0\xa00.60', u'\n', u'\n', u'\n', u'Earnings Per Common Share- Diluted (as reported)', u'\n', u'\n', u'$ \xa0\xa00.11', u'\n', u'\n', u'$ \xa0\xa00.15', u'\n', u'\n', u'$ \xa0\xa0\xa00.44', u'\n', u'\n', u'$ \xa0\xa0\xa00.56', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Fiscal 2004 and 2003 Condensed Balance Sheet Highlights', u'\n', u'(in thousands) (unaudited):', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'As of the Period Ended', u'\n', u'June 30', u'\n', u'\n', u'\xa0', u'\n', u'\n', u' ', u'2004', u'\n', u'\n', u'2003', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Cash and Cash Equivalents', u'\n', u'\n', u'$ 10,213', u'\n', u'\n', u'$ \xa0\xa07,525', u'\n', u'\n', u'\n', u'Working Capital', u'\n', u'\n', u'$ \xa0\xa09,783 ', u'\n', u'\n', u'$ \xa0\xa04,241', u'\n', u'\n', u'\n', u"Stockholders' Equity", u'\n', u'\n', u'$ 30,065', u'\n', u'\n', u'$ 23,935', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine', u'\xe4', u'\n, Hemocare\xae, LifeLine\xae and LifeTrak\xae (blood bank), WORx\xae, Pharmakon\xae, and Digimedics\u2122 (pharmacy), Surgiware\u2122 and Perioperative Solutions\u2122 (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.', u'\n', u'\n', u'#\t\t#\t\t#', u'\n', u'\n', u'Certain statements in this press release may constitute "forward-looking\'\' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act\'\') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company\'s Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements. ', u'\n', u'\n', u'8/31/04', u'\n', u'\n', u'\xa0', u'\n', u'\n\n\n\n\n\n-----END PRIVACY-ENHANCED MESSAGE-----\n']